Lower Respiratory Tract Infection
📧 Sign up to get email alerts when something new happens for Lower Respiratory Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-02-17FDA Approved: CEFACLOR — Original Application (Azorian Pharma, LLC)
The FDA approved Azorian Pharma, LLC's original application for Cefaclor (generic) for treating susceptible bacterial infections including r…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for amoxicillin and clavulanate potassium, authorizing the marketing of thi…
-
FDA approval · 2011-10-26FDA Approved: CEFOTETAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for cefotetan from Hikma Pharmaceuticals USA Inc., authorizing a generic cefotetan product.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
A completed clinical trial in Thailand evaluated recovery time in patients with upper or lower respiratory tract infections treated with Kla…
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Non-influenza Etiologies of Acute Respiratory Illness in Southeast Asia
The study on non-influenza etiologies of acute respiratory illness in Southeast Asia has completed data collection, focusing on lower respir…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid® Granules for Oral Suspension.
A completed clinical trial evaluated recovery time in children with lower respiratory tract infections treated with Klacid granules for oral…
-
FDA approval · 2011-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium (Hikma Pharmaceuticals USA Inc.), updating the product…
-
CLINICAL_TRIALS trial_result · 2008-09-23Clinical Trial Update: Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study [NA]
This clinical trial evaluated whether guiding antibiotic therapy with procalcitonin levels affects hospitalization and antibiotic use in pat…
-
CLINICAL_TRIALS research · 2008-05-20Clinical Trial Update: An Observational Study of Cough / Lower Respiratory Tract Infection (LRTI) in Primary Care
An observational study conducted in primary care to evaluate cough and lower respiratory tract infections; the study is completed.
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid) [Phase 4]
A Phase 4 clinical trial update (PRIMAKid) on prevention and management of recurrent upper and lower respiratory tract infections in childre…
-
FDA approval · 2007-10-31FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Hospira, Inc)
FDA approved a supplemental application for ampicillin/sulbactam from Hospira for the existing product (Unasyn).